-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Lung cancer is the most common type of cancer in China.
Lung cancer is the most common type of cancer in China.
Early diagnosis and early treatment move towards precise intelligence Early diagnosis and early treatment move towards precise intelligence
Surgery is the standard treatment for early-stage lung cancer.
Surgery is the standard treatment for early-stage lung cancer.
Zhao Heng, Honorary Director of the Thoracic Surgery Department of Shanghai Chest Hospital and Standing Committee Member of the Thoracic and Cardiovascular Surgery Branch of the Chinese Medical Association, said: " The early diagnosis and early treatment of lung cancer is being upgraded to intelligence and precision
Different from most of the current lung cancer science popularization on the market, which is mainly based on explanations, doctors who participate in " lung's supplementary advice" not only " move the mouth " but also " hands - on " , and intuitively visualize some of the surgical techniques under the microscope in the minimally invasive surgical treatment of lung cancer.
The lung is a human organ with a complex structure.
Many well-known experts including Professor Zhao Heng and Li Hecheng, Director of Thoracic Surgery, Ruijin Hospital Affiliated to Shanghai Jiaotong University, Zhou Min, Deputy Director of Department of Respiratory and Critical Care Medicine, Ruijin Hospital, and Gu Ye, Deputy Director of Endoscopy Center of Shanghai Pulmonary Hospital Affiliated to Tongji University.
Image: Roundtable discussion session
Image: Roundtable discussion sessionDouble support, add a buff to life
Double support, add a buff to life Double support, add a buff to lifeLi Hecheng, director of thoracic surgery at Ruijin Hospital, said: "For popular science activities such as " lung ' assist ' good words, the most needed information is to encourage the public - especially those with high-risk factors such as family history and smoking history - to participate in screening.
Li Hecheng, director of thoracic surgery at Ruijin Hospital, said: "For popular science activities such as " lung ' assist ' good words, the most needed information is to encourage the public - especially those with high-risk factors such as family history and smoking history - to participate in screening.
Zhou Min, deputy director of the Department of Respiratory and Critical Care Medicine at Ruijin Hospital, said: " For some patients with specific stages, after undergoing surgical resection, they also need to receive adjuvant drug therapy, such as adjuvant chemoradiotherapy, adjuvant targeted therapy, adjuvant Immunotherapy, etc.
In addition to doctors and the media, the series of " Lungs Helping Good Words " also gathered two key industrial forces of medical technology and pharmaceuticals .
At the launching ceremony, Shan Yong, Vice President of Medtronic Innovative Surgery China, said: " In addition to providing surgeons with various surgical tools, Medtronic Innovative Surgery has been committed to breaking through industry boundaries around major diseases, building a diagnosis and treatment ecosystem, and improving patients.
Photo: Mr.
Photo: Mr.
Zhen Zhicheng, head of the lung cancer treatment field of Roche Pharmaceuticals in China, said: " Roche has always adhered to the concept of ' the needs of patients first ' and has been rooted in the field of lung cancer for a long time, targeting multiple targets such as lung cancer targeted therapy, tumor anti-angiogenesis, and lung cancer immunotherapy.
Picture: Mr.
Zhen Zhicheng speaking
Zhen Zhicheng speaking
Zhang Wei, senior business director of Medtronic's Innovative Surgical Growth Platform Division, and Hou Huitao, head of Roche's China Lung Cancer Ecological Immunity Market, also participated in the launching ceremony
.
.
leave a message here